ATL shifts cardiology management
Ultrasound vendor ATL promoted several sales officers in its cardiology organization this month. The company expanded the duties of Bob Dockendorff, vice president of North American sales, to include additional responsibility for its U.S. cardiology
Ultrasound vendor ATL promoted several sales officers in its cardiology organization this month. The company expanded the duties of Bob Dockendorff, vice president of North American sales, to include additional responsibility for its U.S. cardiology sales unit. William Doherty, formerly vice president of Bothell, WA-based ATLs U.S. cardiology sales, has been promoted to the post of vice president of the companys global cardiology business development. Doherty will work with the companys global distribution and marketing groups. Finally, ATL promoted Allan Criss to the position of vice president, U.S. cardiology sales, reporting to Dockendorff. ATL expects the moves to unify its North American sales distribution structure and increase its focus on its global cardiology business.
FDA Grants Fast Track Designation to Emerging Agent for Brain PET Imaging
June 11th 2025Currently being evaluated in a phase 2b clinical trial, the 18F-RAD101 PET imaging agent garnered the FDA’s fast track designation for distinguishing between recurrent disease and treatment impact for brain metastases derived from solid tumors.
New PSMA PET Prep Product Now Available in the U.S.
June 11th 2025Offering an extended shelf life, the FDA-approved Gozellix, a preparation kit for gallium-68 (68Ga) gozetotide injection, is indicated for use in PSMA PET imaging of prostate cancer patients with suspected recurrence or metastasis.
